Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey
About this trial
Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.
Eligibility criteria
Qualifiers
Patient is aged 18 years or older at time of consent
Patient has suspected or confirmed benign vocal fold lesion
Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
Patient is English or Spanish speaking
Disqualifiers
Patient is not 18 years of age or older at consent date
Patient does not speak English or Spanish
Patient is currently pregnant or plans to become pregnant prior to their study procedure
Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
Trial design
Treatments tested in this trial
- Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension)
- Superior laryngeal nerve block - Placebo (saline)
Treatment groups
28 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov